Key facts
- Notable investors include OpenSky Ventures.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Sunny Within
- ·The full record, as it builds
Funding rounds
No funding rounds for Sunny Within are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Sunny Within
Operator of a Liposomal supplements company intended to get nutrients deep inside cells. The company's liposomal formulas deliver nutrients via liposomes, microscopic bubbles that mimic cells and help protect the formula during digestion until it reaches the small intestine, where it can be more efficiently absorbed by the cells in your intestinal wall, enabling people to age their cells brilliantly.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Agoura Hills, CA, United States
- Founded
- 2023
- Employees
- 3
- Website
- sunnywithin.com/
- Ownership
- Privately Held (backing)
Sunny Within doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Sunny Within shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Sunny Within in its N-PORT filings yet. We sweep new filings monthly.